Benzinga | Jul 30, 2020 12:38PM EDT

Oppenheimer Maintains Outperform on United Therapeutics, Raises Price Target to $165

Oppenheimer maintains United Therapeutics (NASDAQ:UTHR) with a Outperform and raises the price target from $155 to $165.